Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1976 1
1977 2
1978 1
1979 1
1982 1
1983 2
1986 2
1987 2
1988 1
1989 2
1990 5
1991 3
1992 4
1993 2
1994 2
1995 5
1996 4
1997 1
1998 4
1999 7
2000 1
2002 1
2003 2
2004 9
2005 2
2006 7
2007 11
2008 9
2009 11
2010 9
2011 6
2012 11
2013 10
2014 14
2015 12
2016 17
2017 34
2018 21
2019 24
2020 31
2021 25
2022 27
2023 20
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Results by year

Filters applied: . Clear all
Page 1
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Demaria O, Gauthier L, Vetizou M, Blanchard Alvarez A, Vagne C, Habif G, Batista L, Baron W, Belaïd N, Girard-Madoux M, Cesari C, Caratini M, Bosco F, Benac O, Lopez J, Fenis A, Galluso J, Trichard S, Carrette B, Carrette F, Maguer A, Jaubert S, Sansaloni A, Letay-Drouet R, Kosthowa C, Lovera N, Dujardin A, Chanuc F, Le Van M, Bokobza S, Jarmuzynski N, Fos C, Gourdin N, Remark R, Lechevallier E, Fakhry N, Salas S, Deville JL, Le Grand R, Bonnafous C, Vollmy L, Represa A, Carpentier S, Rossi B, Morel A, Cornen S, Perrot I, Morel Y, Vivier E. Demaria O, et al. Among authors: salas s. Cell Rep Med. 2022 Oct 18;3(10):100783. doi: 10.1016/j.xcrm.2022.100783. Cell Rep Med. 2022. PMID: 36260981 Free PMC article.
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial.
Harrington KJ, Ferris RL, Gillison M, Tahara M, Argiris A, Fayette J, Schenker M, Bratland Å, Walker JWT, Grell P, Even C, Chung CH, Redman R, Coutte A, Salas S, Grant C, de Azevedo S, Soulières D, Hansen AR, Wei L, Khan TA, Miller-Moslin K, Roberts M, Haddad R. Harrington KJ, et al. Among authors: salas s. JAMA Oncol. 2023 Jun 1;9(6):779-789. doi: 10.1001/jamaoncol.2023.0147. JAMA Oncol. 2023. PMID: 37022706 Free PMC article.
What causes pre-eclampsia?
Salas SP. Salas SP. Baillieres Best Pract Res Clin Obstet Gynaecol. 1999 Mar;13(1):41-57. doi: 10.1053/beog.1999.0005. Baillieres Best Pract Res Clin Obstet Gynaecol. 1999. PMID: 10746092 Review.
[Impact of nutritional factors during and after cancer].
Ancellin R, Cottet V, Dossus L, Fassier P, Gaillot de Saintignon J, Ginhac J, Romieu I, Salas S, Schneider S, Srour B, Touillaud M, Touvier M, Latino-Martel P. Ancellin R, et al. Among authors: salas s. Bull Cancer. 2021 May;108(5):455-464. doi: 10.1016/j.bulcan.2021.03.001. Epub 2021 Apr 6. Bull Cancer. 2021. PMID: 33836862 Review. French.
[Bereavement without farewell].
Salas SP. Salas SP. Rev Med Chil. 2013 Apr;141(4):546-7. doi: 10.4067/S0034-98872013000400020. Rev Med Chil. 2013. PMID: 23900380 Free article. Spanish. No abstract available.
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
de Nonneville A, Salas S, Bertucci F, Sobinoff AP, Adélaïde J, Guille A, Finetti P, Noble JR, Churikov D, Chaffanet M, Lavit E, Pickett HA, Bouvier C, Birnbaum D, Reddel RR, Géli V. de Nonneville A, et al. Among authors: salas s. EMBO Mol Med. 2022 Oct 10;14(10):e15859. doi: 10.15252/emmm.202215859. Epub 2022 Aug 3. EMBO Mol Med. 2022. PMID: 35920001 Free PMC article.
340 results